Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 19 studies | 52% ± 12% | |
lung | 16 studies | 45% ± 16% | |
intestine | 12 studies | 37% ± 16% | |
kidney | 8 studies | 42% ± 11% | |
eye | 6 studies | 26% ± 10% | |
pancreas | 5 studies | 40% ± 18% | |
liver | 5 studies | 39% ± 15% | |
lymph node | 5 studies | 45% ± 19% | |
bone marrow | 4 studies | 33% ± 18% | |
uterus | 4 studies | 45% ± 16% | |
breast | 4 studies | 34% ± 10% | |
adrenal gland | 3 studies | 41% ± 12% | |
esophagus | 3 studies | 43% ± 26% | |
placenta | 3 studies | 29% ± 16% | |
prostate | 3 studies | 36% ± 13% | |
brain | 3 studies | 31% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 2983.31 | 258 / 258 | 100% | 305.43 | 230 / 230 |
bladder | 100% | 2707.81 | 21 / 21 | 100% | 230.15 | 504 / 504 |
esophagus | 100% | 2660.20 | 1445 / 1445 | 100% | 198.01 | 183 / 183 |
intestine | 100% | 3191.97 | 966 / 966 | 100% | 286.40 | 527 / 527 |
liver | 100% | 1573.95 | 226 / 226 | 100% | 216.60 | 406 / 406 |
ovary | 100% | 1979.05 | 180 / 180 | 100% | 531.51 | 430 / 430 |
skin | 100% | 2145.59 | 1809 / 1809 | 100% | 246.81 | 472 / 472 |
stomach | 100% | 2073.26 | 359 / 359 | 100% | 265.01 | 286 / 286 |
thymus | 100% | 2173.82 | 653 / 653 | 100% | 204.98 | 605 / 605 |
uterus | 100% | 1788.49 | 170 / 170 | 100% | 235.49 | 459 / 459 |
prostate | 100% | 2377.29 | 245 / 245 | 100% | 224.84 | 501 / 502 |
brain | 100% | 1887.82 | 2640 / 2642 | 100% | 189.95 | 704 / 705 |
kidney | 100% | 2846.07 | 89 / 89 | 100% | 219.44 | 899 / 901 |
lung | 100% | 1748.27 | 576 / 578 | 100% | 162.98 | 1153 / 1155 |
pancreas | 99% | 1063.40 | 325 / 328 | 100% | 186.22 | 178 / 178 |
breast | 100% | 2003.15 | 459 / 459 | 99% | 182.96 | 1107 / 1118 |
adipose | 100% | 2241.67 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 443.60 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 406.98 | 29 / 29 |
muscle | 100% | 4069.04 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2282.39 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 208.93 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 119.43 | 1 / 1 |
blood vessel | 100% | 1401.49 | 1331 / 1335 | 0% | 0 | 0 / 0 |
heart | 100% | 3139.87 | 857 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 2226.08 | 918 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0097250 | Biological process | mitochondrial respirasome assembly |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0070469 | Cellular component | respirasome |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005739 | Cellular component | mitochondrion |
Gene name | HIGD2A |
Protein name | HIG1 domain family member 2A, mitochondrial (RCF1 homolog B) (RCF1b) |
Synonyms | |
Description | FUNCTION: Proposed subunit of cytochrome c oxidase (COX, complex IV), which is the terminal component of the mitochondrial respiratory chain that catalyzes the reduction of oxygen to water. May be involved in cytochrome c oxidase activity. May play a role in the assembly of respiratory supercomplexes. . |
Accessions | Q9BW72 ENST00000274787.3 |